The startup develops interventional and implantable medical devices utilizing domestically produced ePTFE to enhance procedures for peripheral vascular diseases and tumor interventions. Their technology provides healthcare professionals with reliable tools to improve patient outcomes in complex vascular and oncological treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Current interventional and implantable medical devices for peripheral vascular disease, tumor intervention, and hemodialysis access often rely on imported expanded polytetrafluoroethylene (ePTFE) materials, leading to supply chain vulnerabilities and increased costs. The limited availability of domestically produced, medical-grade ePTFE hinders innovation and restricts the development of advanced treatment options.
Solution
Mei Medical develops and manufactures interventional and implantable medical devices using domestically produced, medical-grade ePTFE, addressing critical needs in peripheral vascular, tumor intervention, and hemodialysis access procedures. By focusing on ePTFE-based solutions, the company aims to provide healthcare professionals with reliable tools that improve patient outcomes while ensuring a secure and cost-effective supply chain. Their products include ePTFE tubes, membranes, covered stents, and artificial blood vessels, all designed to promote tissue integration and minimize rejection. The company's integrated approach, encompassing R&D, production, and commercialization, allows for rapid innovation and responsiveness to clinical needs.
Target Audience
The primary target audience includes interventional radiologists, vascular surgeons, oncologists, and nephrologists specializing in peripheral vascular disease, tumor intervention, and hemodialysis access, as well as hospitals and clinics performing these procedures.
Features
- Development of ePTFE-based medical devices for peripheral vascular intervention, tumor intervention, and hemodialysis access.
- Domestically produced, medical-grade ePTFE material platform to ensure supply chain security.
- Product pipeline includes覆膜支架 (covered stents) and 透析人工血管 (artificial blood vessels).
- Manufacturing capabilities include ePTFE管材 (tubes) and 膜材 (membranes).
- Advanced cleanroom facilities for the production of implantable devices.
- Focus on biocompatibility to facilitate tissue integration and minimize adverse reactions.
- R&D centers in both China and the United States.